跳至主要内容
临床试验/DRKS00012471
DRKS00012471招募中未知

Characterization of the extent, the time course and the underlying pathomechanism of the elevated skin reactivity of chronic urticaria patients in comparison with healthy test subjects. - Skinsensitivity in chronic urticaria - SkisiC

Charite-Universitätsmedizin Berlin, Klinik für Dermatologie und Allergologie0 个研究点目标入组 95 人开始时间: 2017年5月31日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Adults (18 years or older)
  • Able to read, understand and willing to sign the informed consent form and abide with study procedures
  • Willing, committed and able to complete all study-related procedures
  • Arm1: Diagnosis of urticaria for more than 6 weeks
  • Patients may have additional concomitant disease, but only one dominant skin disease.
  • No participation in other clinical trials 4 weeks before in this study

排除标准

  • Concurrent/ongoing treatment with immunosuppressives (e.g. cyclosporine, methotrexate, dapsone, systemic Corticosteroids or others) within 4 weeks or 5 half lives prior to study entry whichever is longer
  • Concurrent/ongoing treatment with Omomalizumab within 3 months prior to study entry
  • Prior or concurrent treatment with antihistamines within the last 5 days.
  • Significant medical condition rendering the patient immunocompromised or not suitable for a clinical trial
  • Lactating females or pregnant females
  • Any medical condition which, in the opinion of the Investigator, would interfere with participation in the study or place the subject at risk
  • Intake of leukotriene antagonists within 7 days prior to study entry
  • History of hypersensitivity/allergy to local anesthetics

研究者

发起方
Charite-Universitätsmedizin Berlin, Klinik für Dermatologie und Allergologie

相似试验